Abstract
Sjögren syndrome (SS) is a chronic autoimmune disease characterized by inflammation of salivary and lacrymal glands, causing oral and ocular dryness [1]. The syndrome was named by Swedish ophthalmologist Henrik Sjögren, who identified it in 1933. SS prevalence ranges between 0. 5 % and 3 % and the syndrome is more likely to affect females over 40 years old, especially in menopause [2, 3]. It is a slowly progressing, non-life-threatening disease with a 10-year cumulative survival rate of over 90 % [4].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Oral and Craniofacial Science
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
